5024 related articles for article (PubMed ID: 6409969)
1. Selective aberration and pigment loss in melanosomes of malignant melanoma cells in vitro by glycosylation inhibitors: premelanosomes as glycoprotein.
Mishima Y; Imokawa G
J Invest Dermatol; 1983 Aug; 81(2):106-14. PubMed ID: 6409969
[TBL] [Abstract][Full Text] [Related]
2. Importance of glycoproteins in the initiation of melanogenesis: an electron microscopic study of B-16 melanoma cells after release from inhibition of glycosylation.
Imokawa G; Mishima Y
J Invest Dermatol; 1986 Sep; 87(3):319-25. PubMed ID: 3734483
[TBL] [Abstract][Full Text] [Related]
3. Loss of melanogenic properties in tyrosinases induced by glucosylation inhibitors within malignant melanoma cells.
Imokawa G; Mishima Y
Cancer Res; 1982 May; 42(5):1994-2002. PubMed ID: 6802485
[TBL] [Abstract][Full Text] [Related]
4. Molecular and biological control of melanogenesis through tyrosinase genes and intrinsic and extrinsic regulatory factors.
Mishima Y
Pigment Cell Res; 1994 Dec; 7(6):376-87. PubMed ID: 7761345
[TBL] [Abstract][Full Text] [Related]
5. Analysis of carbohydrate properties essential for melanogenesis in tyrosinases of cultured malignant melanoma cells by differential carbohydrate processing inhibition.
Imokawa G
J Invest Dermatol; 1990 Jul; 95(1):39-49. PubMed ID: 2114451
[TBL] [Abstract][Full Text] [Related]
6. Analysis of initial melanogenesis including tyrosinase transfer and melanosome differentiation through interrupted melanization by glutathione.
Imokawa G
J Invest Dermatol; 1989 Jul; 93(1):100-7. PubMed ID: 2501395
[TBL] [Abstract][Full Text] [Related]
7. [Control of melanogenesis by glycosylation inhibitors and the inhibitory effect of interferon on melanoma metastasis].
Mishima Y; Ueda M
Gan To Kagaku Ryoho; 1985 Jun; 12(6):1235-44. PubMed ID: 2408578
[TBL] [Abstract][Full Text] [Related]
8. Origin of melanosome structures and cytochemical localizations of tyrosinase activity in differentiating epidermal melanocytes of newborn mouse skin.
Hirobe T
J Exp Zool; 1982 Dec; 224(3):355-63. PubMed ID: 6818322
[TBL] [Abstract][Full Text] [Related]
9. Suppression of pigmentation in mouse melanoma cells by 5-bromodeoxyuridine: effects on tyrosinase activity and melanosome formation.
Wrathall JR; Oliver C; Silagi S; Essner E
J Cell Biol; 1973 May; 57(2):406-23. PubMed ID: 4633171
[TBL] [Abstract][Full Text] [Related]
10. Human malignant melanoma. Melanosomal polymorphism and the ultrastructural dopa reaction.
Hunter JA; Paterson WD; Fairley DJ
Br J Dermatol; 1978 Apr; 98(4):381-90. PubMed ID: 638044
[TBL] [Abstract][Full Text] [Related]
11. Analyses of mixed melanogenesis in tyrosinase cDNA-transfected human amelanotic melanoma cells.
Ando O; Mishima Y; Hanada S; Suemoto Y; Atobe J; Kurimoto M
J Invest Dermatol; 1993 Dec; 101(6):864-70. PubMed ID: 8245515
[TBL] [Abstract][Full Text] [Related]
12. Immunoelectron microscopic localization of tyrosinase in the mouse melanocyte.
Yamamoto H; Takeuchi T
J Histochem Cytochem; 1981 Aug; 29(8):953-8. PubMed ID: 6792273
[TBL] [Abstract][Full Text] [Related]
13. Functional analysis of tyrosinase isozymes of cultured malignant melanoma cells during the recovery period following interrupted melanogenesis induced by glycosylation inhibitors.
Imokawa G; Mishima Y
J Invest Dermatol; 1984 Sep; 83(3):196-201. PubMed ID: 6432920
[TBL] [Abstract][Full Text] [Related]
14. Altered protein localization in melanocytes from Hermansky-Pudlak syndrome: support for the role of the HPS gene product in intracellular trafficking.
Boissy RE; Zhao Y; Gahl WA
Lab Invest; 1998 Sep; 78(9):1037-48. PubMed ID: 9759648
[TBL] [Abstract][Full Text] [Related]
15. Co-regulation of melanin precursors and tyrosinase in human pigment cells: roles of cysteine and glutathione.
Benathan M; Virador V; Furumura M; Kobayashi N; Panizzon RG; Hearing VJ
Cell Mol Biol (Noisy-le-grand); 1999 Nov; 45(7):981-90. PubMed ID: 10644002
[TBL] [Abstract][Full Text] [Related]
16. Melanin monomers within coated vesicles and premelanosomes in melanin synthesizing cells.
Hatta S; Mishima Y; Ichihashi M; Ito S
J Invest Dermatol; 1988 Aug; 91(2):181-4. PubMed ID: 3135338
[TBL] [Abstract][Full Text] [Related]
17. Characterization of melanogenesis and morphogenesis of melanosomes by physicochemical properties of melanin and melanosomes in malignant melanoma.
Jimbow K; Miyake Y; Homma K; Yasuda K; Izumi Y; Tsutsumi A; Ito S
Cancer Res; 1984 Mar; 44(3):1128-34. PubMed ID: 6318981
[TBL] [Abstract][Full Text] [Related]
18. Melanogenic regulatory factors in coated vesicles from melanoma cells.
Chakraborty AK; Mishima Y; Inazu M; Hatta S; Ichihashi M
J Invest Dermatol; 1989 Nov; 93(5):616-20. PubMed ID: 2571641
[TBL] [Abstract][Full Text] [Related]
19. The presence of stage II melanosomes (premelanosomes) in neoplasms other than melanomas.
Szpak CA; Shelburne J; Linder J; Klintworth GK
Mod Pathol; 1988 Jan; 1(1):35-43. PubMed ID: 3237689
[TBL] [Abstract][Full Text] [Related]
20. Depigmenting effects of calcium D-pantetheine-S-sulfonate on human melanocytes.
Franchi J; Coutadeur MC; Marteau C; Mersel M; Kupferberg A
Pigment Cell Res; 2000 Jun; 13(3):165-71. PubMed ID: 10885675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
